Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $456M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 2,341,667 | $43.63M | 9.6% | $20.54 | -8.6% | COM | 252828108 |
| AVBP | ARRIVENT BIOPHARMA INC | 1,946,054 | $42.37M | 9.3% | $20.73 | +0.2% | COM | 04272N102 |
| — | VERONA PHARMA PLC | 337,000 | $31.87M | 7.0% | $44.94 | — | SPONSORED ADS | 925050106 |
| TSHA | TAYSHA GENE THERAPIES INC | 12,592,500 | $29.09M | 6.4% | $2.19 | -0.6% | COM SHS | 877619106 |
| SPRY | ARS PHARMACEUTICALS INC | 1,350,000 | $23.56M | 5.2% | $13.32 | +8.3% | COM | 82835W108 |
| GOSS | GOSSAMER BIO INC | 18,350,000 | $22.57M | 5.0% | $1.89 | -42.4% | COM | 38341P102 |
| OCUL | OCULAR THERAPEUTIX INC | 2,425,000 | $22.5M | 4.9% | $7.10 | +10.3% | COM | 67576A100 |
| — | MERUS N V | 389,000 | $20.46M | 4.5% | $44.25 | — | COM | N5749R100 |
| TRVI | TREVI THERAPEUTICS INC | 3,672,000 | $20.09M | 4.4% | $4.91 | +26.7% | COM | 89532M101 |
| COGT | COGENT BIOSCIENCES INC | 2,763,000 | $19.84M | 4.4% | $9.86 | -43.8% | COM | 19240Q201 |
| ATYR | ATYR PHARMA INC | 3,820,000 | $19.37M | 4.3% | $3.52 | +11.7% | COM NEW | 002120202 |
| APLS | APELLIS PHARMACEUTICALS INC | 903,500 | $15.64M | 3.4% | $47.09 | -60.7% | COM | 03753U106 |
| NUVB | NUVATION BIO INC | 7,691,334 | $15M | 3.3% | $2.99 | -30.4% | COM CL A | 67080N101 |
| — | TOURMALINE BIO INC | 905,000 | $14.47M | 3.2% | $15.21 | — | COM | 89157D105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,273,333 | $14.4M | 3.2% | $10.36 | +18.0% | COM | 483497103 |
| — | MIND MEDICINE MINDMED INC | 2,130,000 | $13.82M | 3.0% | $8.34 | — | COM NEW | 60255C885 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,030,000 | $13.53M | 3.0% | $7.34 | — | SPONSORED ADS | 152309100 |
| PHVS | PHARVARIS N V | 672,595 | $11.84M | 2.6% | $18.74 | -14.0% | COM | N69605108 |
| KYMR | KYMERA THERAPEUTICS INC | 266,000 | $11.61M | 2.5% | $34.43 | 0.0% | COM | 501575104 |
| ABVX | ABIVAX SA | 1,267,000 | $9.693M | 2.1% | $6.29 | — | SPONSORED ADS | 00370M103 |
| DBVT | DBV TECHNOLOGIES S A | 1,018,021 | $9.315M | 2.0% | $9.15 | — | SPONSORED ADS | 23306J309 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 1,115,000 | $7.694M | 1.7% | $40.87 | -82.2% | COM NEW | 21833P301 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 148,000 | $6.986M | 1.5% | $43.09 | -5.5% | CLASS A ORD | 61559X104 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 1,000,000 | $4.77M | 1.0% | $6.18 | 0.0% | COM NEW | 90466Y202 |
| NGNE | NEUROGENE INC | 303,000 | $4.53M | 1.0% | $37.29 | -57.9% | COM | 64135M105 |
| BBOT | HELIX ACQUISITION CORP II | 250,000 | $2.663M | 0.6% | $10.35 | +4.5% | CL A ORD SHS | G4444H101 |
| MAZE | MAZE THERAPEUTICS INC | 177,667 | $2.18M | 0.5% | $12.04 | -13.6% | COM | 578784100 |
| KLRS | KALARIS THERAPEUTICS INC | 360,000 | $961K | 0.2% | $9.79 | -53.9% | COM | 482929106 |
| ERAS | ERASCA INC | 700,000 | $889K | 0.2% | $2.74 | -51.2% | COM | 29479A108 |
| — | NUVATION BIO INC | 154,112 | $301K | 0.1% | $1.77 | — | *W EXP 02/10/202 | 67080N119 |